Top 10 Medical Equipment Stocks with Highest Upside: BLTI, CBMX, VSCI, OTIX, WHRT, APT, DCTH, DSCI, ANPI, ETRM (Aug 30, 2010)

Below are the top 10 Medical Equipment stocks with highest upside potential, based on the difference between current price and Wall Street analysts' average target price.

Biolase Technology, Inc. (NASDAQ:BLTI) has the 1st highest upside potential in this segment of the market. Its upside is 455.6%. Its consensus target price is $4.00 based on the average of all estimates. CombiMatrix Corporation (NASDAQ:CBMX) has the 2nd highest upside potential in this segment of the market. Its upside is 396.7%. Its consensus target price is $15.00 based on the average of all estimates. Vision-Sciences, Inc. (NASDAQ:VSCI) has the 3rd highest upside potential in this segment of the market. Its upside is 328.6%. Its consensus target price is $6.00 based on the average of all estimates. Otix Global, Inc. (NASDAQ:OTIX) has the 4th highest upside potential in this segment of the market. Its upside is 283.6%. Its consensus target price is $15.00 based on the average of all estimates. WorldHeart Corporation (USA) (NASDAQ:WHRT) has the 5th highest upside potential in this segment of the market. Its upside is 252.1%. Its consensus target price is $7.50 based on the average of all estimates.

Alpha Pro Tech, Ltd. (AMEX:APT) has the 6th highest upside potential in this segment of the market. Its upside is 251.6%. Its consensus target price is $5.63 based on the average of all estimates. Delcath Systems, Inc. (NASDAQ:DCTH) has the 7th highest upside potential in this segment of the market. Its upside is 216.6%. Its consensus target price is $19.25 based on the average of all estimates. Derma Sciences, Inc. (NASDAQ:DSCI) has the 8th highest upside potential in this segment of the market. Its upside is 179.6%. Its consensus target price is $13.00 based on the average of all estimates. Angiotech Pharmaceuticals, Inc. (USA) (NASDAQ:ANPI) has the 9th highest upside potential in this segment of the market. Its upside is 177.8%. Its consensus target price is $1.25 based on the average of all estimates. EnteroMedics Inc. (NASDAQ:ETRM) has the 10th highest upside potential in this segment of the market. Its upside is 134.4%. Its consensus target price is $3.75 based on the average of all estimates.